Article Text

Download PDFPDF
Original Article
The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case–control study

Footnotes

  • Collaborators FH-Risk Study Group: Susan Astley, Mary Wilson, David French, Michelle Harvie, Donna Watterson, Paula Stavrinos, Jill Fox, Sarah Sampson, Sarah Ingham, Sarah Sahin, Lynne Fox.

  • Contributors DGE and AB are joint first authors. Conception: DGE, AH and JC. Data acquisition: HB, PS and DGE. Data analysis: AB, JC, DGE and EH. Manuscript writing: all. Approval of final version: all.

  • Funding The study received grant support from the NIHR and the Genesis Breast Cancer Prevention Appeal. This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research (Reference Number RP-PG-0707-10031).

  • Competing interests DGE has received a one-off consultancy fee from Astazeneca. DGE is an NIHR senior investigator.

  • Ethics approval NHS North Manchester Research Committee (08/H1006/77) and University of Manchester ethics committees (08229).

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Data in this article can be shared on request.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Collaborators FH-Risk Study Group: Susan Astley, Mary Wilson, David French, Michelle Harvie, Donna Watterson, Paula Stavrinos, Jill Fox, Sarah Sampson, Sarah Ingham, Sarah Sahin, Lynne Fox.

  • Contributors DGE and AB are joint first authors. Conception: DGE, AH and JC. Data acquisition: HB, PS and DGE. Data analysis: AB, JC, DGE and EH. Manuscript writing: all. Approval of final version: all.

  • Funding The study received grant support from the NIHR and the Genesis Breast Cancer Prevention Appeal. This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research (Reference Number RP-PG-0707-10031).

  • Competing interests DGE has received a one-off consultancy fee from Astazeneca. DGE is an NIHR senior investigator.

  • Ethics approval NHS North Manchester Research Committee (08/H1006/77) and University of Manchester ethics committees (08229).

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Data in this article can be shared on request.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.